News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
223 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17894)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (31)
2 (29)
3 (279)
4 (239)
5 (185)
6 (219)
7 (134)
8 (5)
9 (2)
10 (218)
11 (255)
12 (223)
13 (194)
14 (151)
15 (4)
16 (14)
17 (221)
18 (253)
19 (211)
20 (239)
21 (133)
22 (2)
23 (4)
24 (22)
25 (1)
26 (55)
27 (85)
28 (60)
30 (1)
31 (34)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
30
31
BioForest
Air Methods Contributes to Brain Injury Association of America on Behalf of Former Patient
Donation in name of Whitney Corby to support research, treatment and education for brain injuries
December 12, 2018
·
4 min read
Business
Caribou Biosciences Appoints Dr. Natalie Sacks to Board of Directors
Dr. Sacks is an accomplished industry leader and oncology expert who has played a key role in the development and approval of several oncology therapeutics.
December 12, 2018
·
3 min read
BioMidwest
EDGe Surgical Secures $4 Million in Series A Financing
EDGe Surgical, Inc., a privately held medical device company dedicated to innovative precision measurement solutions for orthopedic surgery, announced today that it has completed $4 million in financing.
December 12, 2018
·
3 min read
Drug Development
GenSight Biologics Reports Sustained Quality of Life Improvements at Week 72 of Phase III REVERSE Clinical Trial of GS010 for the Treatment of Leber Hereditary Optic Neuropathy (LHON)
Composite score and relevant sub-scores in the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) showed sustained improvements at Week 48 and Week 72
December 12, 2018
·
9 min read
Business
NOVADIP BIOSCIENCES appoints Jeff Abbey as CEO
NOVADIP BIOSCIENCES announces that Jeff Abbey will be appointed chief executive officer, effective early 2019, succeeding Jean-François Pollet.
December 12, 2018
·
3 min read
Biotech Bay
Magnetic Insight Raises $18M to Support Commercial Growth of Magnetic Particle Imaging in Cell Therapy, Vascular and Oncology Applications
Magnetic Insight, Inc., a developer and manufacturer of transformational in vivo imaging platforms, announced a Series A financing led by 5AM Ventures.
December 12, 2018
·
2 min read
Business
Lilly and AC Immune Announce License and Collaboration Agreement
Multi-year agreement focuses on Morphomer tau aggregation inhibitors, for the potential treatment of Alzheimer’s disease and other neurodegenerative diseases.
December 12, 2018
·
7 min read
Drug Development
Rodin Therapeutics Announces Initiation of Phase 1 Clinical Trial of a Selective CoREST Inhibitor to Treat Neurologic Diseases
Rodin Therapeutics today announced the initiation of a Phase 1 clinical trial of the company’s lead candidate, RDN-929, a potent and selective HDAC-CoREST inhibitor.
December 12, 2018
·
2 min read
Business
AC Immune and Lilly Announce License and Collaboration Agreement
Multi-year agreement focuses on Morphomer tau aggregation inhibitors, for the potential treatment of Alzheimer’s disease and other neurodegenerative diseases.
December 12, 2018
·
7 min read
Aleph Farms Jump-starts First Cell-Grown Steak
Aleph Farms is shaping the future of meat by turning cow cells into beef cuts, replicating the complex shape, texture and flavor of a steak
December 12, 2018
·
3 min read
Previous
17 of 23
Next